Table 6.

Frequency distribution of malaria-associated anemia pre- and posttreatment with AA, AL, or DHP

	Day of follow-up
	0		1		2		3		7		14		21		28		35		42
	Anemia		Anemia		Anemia		Anemia		Anemia		Anemia		Anemia		Anemia		Anemia		Anemia
Treatment	Y	N	Y	N	Y	N	Y	N	Y	N	Y	N	Y	N	Y	N	Y	N	Y	N	P value*
AA	111	173	120	158	128	152	119	157	97	176	45	228	28	232	28	234	21	232	24	223	< 0.0001
AL	118	180	139	150	139	151	132	158	118	166	66	215	43	223	31	227	27	231	23	228	< 0.0001
DHP	104	205	132	165	141	158	147	152	132	166	59	232	37	243	31	244	26	241	19	237	< 0.0001
All	333	558	390	473	408	461	398	467	347	508	170	675	108	698	90	705	74	704	66	688	< 0.0001
P value†	0.24		0.5		0.86		0.34		0.09		0.12		0.19		0.89		0.69		0.63		–

AA = artesunate–amodiaquine; AL = artemether–lumefantrine; DHP = dihydroartemisinin–piperaquine; N = no, anemia absent; Y = yes, anemia present.

^*Test for trend.

^†Test of proportion.